Cisplatin plus irinotecan versus cisplatin plus gemcitabine in the treatment of advanced or metastatic gallbladder or biliary tract cancer: Results of a randomized phase II trial (NCT01859728)- the Gambit trial

被引:0
|
作者
dos Santos, Lucas Vieira
Faria Pinto, Gustavo Sanches
Souto Ferraz, Mauricio Wagner
Bragagnoli, Arinilda
Santos, Florinda
Haddad, Sarah
Barros, Ana
Cordeiro Dias, Isadora Clarissa
Lima, Joao Paulo S. N.
Abdalla, Kathia C.
机构
[1] Beneficencia Portuguesa Sao Paulo, Sao Paulo, Brazil
[2] Barretos Canc Hosp, Barretos, Brazil
[3] Barretos Canc Ctr, Barretos, Brazil
[4] Hosp Canc Barretos, Barretos, Brazil
[5] AC Camargo Canc Ctr, Sao Paulo, Brazil
[6] Fundacao Fac Med Sao Jose do Rio Preto, Sao Jose Do Rio Preto, Brazil
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
529
引用
收藏
页数:2
相关论文
共 50 条
  • [31] Cisplatin and gemcitabine plus ramucirumab or merestinib or placebo in first-line treatment for advanced or metastatic biliary tract cancer: A double-blind, randomized phase 2 trial
    Valle, J. W.
    Bousmans, N.
    Zhang, W.
    Walgren, R. A.
    Vogel, A.
    ANNALS OF ONCOLOGY, 2016, 27 : vi240
  • [32] Gemcitabine Plus Cisplatin for Advanced Biliary Tract Cancer: A Systematic Review
    Park, Joon Oh
    Oh, Do-Youn
    Hsu, Chiun
    Chen, Jen-Shi
    Chen, Li-Tzong
    Orlando, Mauro
    Kim, Jong Seok
    Lim, Ho Yeong
    CANCER RESEARCH AND TREATMENT, 2015, 47 (03): : 343 - 361
  • [33] Adjuvant Gemcitabine Plus Cisplatin and Chemoradiation in Patients With Gallbladder Cancer A Randomized Clinical Trial
    Ostwal, Vikas
    Patkar, Shraddha
    Engineer, Reena
    Parulekar, Manali
    Mandavkar, Sarika
    Bhargava, Prabhat
    Srinivas, Sujay
    Krishnatry, Rahul
    Gudi, Shivakumar
    Kapoor, Akhil
    Pandey, Durgatosh
    Patel, Swapnil
    Singhal, Abhishek
    Goel, Alok
    Dora, Tapas Kumar
    Chaudhary, Debashish
    Chaugule, Deepali
    Naughane, Deepali
    Daddi, Anuprita
    Patil, Rajshree
    Ankathi, Suman Kumar
    Ramaswamy, Anant
    Goel, Mahesh
    JAMA ONCOLOGY, 2024, 10 (08) : 1116 - 1120
  • [34] Gemcitabine plus cisplatin for advanced transitional cell carcinoma of the urinary tract: A phase II multicenter trial
    Lorusso, V
    Manzione, L
    De Vita, F
    Antimi, M
    Selvaggi, FP
    De Lena, M
    JOURNAL OF UROLOGY, 2000, 164 (01): : 53 - 56
  • [35] COST-EFFECTIVENESS OF GEMCITABINE PLUS CISPLATIN VERSUS GEMCITABINE ALONE FOR TREATMENT OF ADVANCED BILIARY TRACT CANCER IN JAPAN
    Arakawa, I
    Uemura, S.
    Murasawa, H.
    Inoue, T.
    VALUE IN HEALTH, 2013, 16 (07) : A416 - A416
  • [36] Randomized phase III study of gemcitabine, cisplatin plus S-1 versus gemcitabine, cisplatin for advanced biliary tract cancer (KHBO1401-MITSUBA)
    Ioka, Tatsuya
    Kanai, Masashi
    Kobayashi, Shogo
    Sakai, Daisuke
    Eguchi, Hidetoshi
    Baba, Hideo
    Seo, Satoru
    Taketomi, Akinobu
    Takayama, Tadatoshi
    Yamaue, Hiroki
    Takahashi, Masahiro
    Sho, Masayuki
    Kamei, Keiko
    Fujimoto, Jiro
    Toyoda, Masanori
    Shimizu, Junzo
    Goto, Takuma
    Shindo, Yoshitaro
    Yoshimura, Kenichi
    Hatano, Etsuro
    Nagano, Hiroaki
    JOURNAL OF HEPATO-BILIARY-PANCREATIC SCIENCES, 2023, 30 (01) : 102 - 110
  • [37] Modified gemcitabine and oxaliplatin or gemcitabine plus cisplatin in unresectable gallbladder cancer: Results of a phase III randomised controlled trial
    Sharma, Atul
    Mohanti, Bidhu Kalyan
    Chaudhary, Surendra Pal
    Sreenivas, V.
    Sahoo, Ranjit Kumar
    Shukla, Nootan Kumar
    Thulkar, Sanjay
    Pal, Sujoy
    Deo, Surya V.
    Pathy, Sushmita
    Dash, Nihar Ranjan
    Kumar, Sunil
    Bhatnagar, Sushma
    Kumar, Rakesh
    Mishra, Seema
    Sahni, Peush
    Iyer, Venkateswaran K.
    Raina, Vinod
    EUROPEAN JOURNAL OF CANCER, 2019, 123 : 162 - 170
  • [38] Randomized phase II trial of S-1 and cisplatin versus gemeitabine and cisplatin in advanced biliary tract adenocarcinoma
    Kang, M.
    Lee, J.
    Kim, T.
    Lee, S.
    Park, D.
    Seo, D.
    Kim, M.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [39] Cetuximab plus gemcitabine and cisplatin compared with gemcitabine and cisplatin alone in patients with advanced pancreatic cancer: a randomised, multicentre, phase II trial
    不详
    LANCET ONCOLOGY, 2008, 9 (01): : 39 - 44
  • [40] A RANDOMIZED TRIAL OF CISPLATIN VERSUS CISPLATIN PLUS METHOTREXATE IN THE MANAGEMENT OF ADVANCED BLADDER-CANCER
    HILLCOAT, B
    RAGHAVAN, D
    BRITISH JOURNAL OF UROLOGY, 1988, 61 (01): : 85 - 85